Carcinoid heart disease registry study
Part of Cancer, Heart & circulation clinical trials.
This study collects information from patients with neuroendocrine tumors that affect the heart. It aims to better understand and treat this rare condition by gathering data from routine tests and procedures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with a neuroendocrine tumor that affects your heart valves.
- Tests show your heart has at least moderate valve damage related to your tumor.
- A blood test shows a high level of NT-proBNP (a heart stress marker).
- Your medical records include heart ultrasound (echocardiogram) and lab results.
- You can provide permission for your data to be used in this registry.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study sets up a national registry to collect information about people with neuroendocrine tumors. It helps researchers understand these cancers better and improve care over time.
This study looks at neuroendocrine tumors by collecting tissue (when available) and tracking how the disease behaves over time. It may help researchers better understand these cancers, including rare cases of adrenocortical cancer.
This study keeps a worldwide record of people with neuroendocrine tumors to learn about care patterns and outcomes. It may help your doctors and future patients by improving how these tumors are monitored and treated.
This study builds a registry (a secure database) of people who have had cervical neuroendocrine cancer, including small cell or large cell types. It helps researchers learn more about these cancers and may improve future care and research planning.
This is a registry (a research database) for people who are being followed in cardio-oncology, which means care for heart problems related to cancer or cancer treatments. It may help doctors better understand these conditions and improve future care.
This study is a global registry for people with a rare heart cancer called cardiac angiosarcoma. It collects information on treatments and outcomes to help doctors better understand the disease and improve care.
Hear when a new Neuroendocrine Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.